Keeping up with Belgian patent litigation: Year case law review 2020 By Annsley Merelle Ward on Tuesday, July 13, 2021 amerikat; belgium belgian patent litigation CJEU Enforcement Directive keeping up with mylan SPC regulation Teva +
BREAKING: Court of Appeal frames Article 3(a) test as one of "claim requirement", but still upholds Truvada SPC invalidity By Annsley Merelle Ward on Thursday, December 19, 2019 #IPKat Actavis v Boehringer AG Opinion article 3(a) CJEU Court of Appeal Lilly v HGS Lord Justice Arnold lord justice floyd medeva regulatory approval SPC regulation Teva Teva v Gilead +
SPC manufacturing and stockpiling waiver comes into force By Dr Rose Hughes on Monday, July 01, 2019 european commission manufacturing waiver patents proposed regulation SPC SPC regulation stockpiling waiver +
SPCs based on a second marketing authorisation - the fight continues (Novartis C-354/19) By Dr Rose Hughes on Friday, June 28, 2019 article 3(c) biologics canakinumab CJEU Ilaris monocolonal antibody Novartis patents pharmaceutical industry Second medical use SPC SPC regulation Supplementary Protection Certificate +
Fordham 27 (Report 12): SPCs By Annsley Merelle Ward on Tuesday, April 30, 2019 AmeriKat CJEU event report fordham 2019 manufacturing waiver marketing authorisation pharma R&D regulatory approval SPC SPC manufacturing waiver SPC regulation +
BREAKING: CJEU delivers another blow to SPC owners in Abraxis Article 3(d) (or 1(b)) battle By Annsley Merelle Ward on Thursday, March 21, 2019 Abraxis AmeriKat Article 1(b) Article 3(d) CJEU MIT Neurim pharmaceutical industry SPC SPC regulation Yissum +
Radical changes in the SPC system in the EU: SPC export and stockpiling exception soon a reality By Frantzeska Papadopoulou on Tuesday, February 26, 2019 export exception Frantzeska Papadopoulou SPC regulation stockpilling +